Intense Exercise May Be Risky in Moderate to Severe Stenosis at AshTip Solution.

VIENNA — Resolution of non-alcoholic steatohepatitis (NASH), and reduction of fibrosis on liver biopsy were achieved with the oral, thyroid hormone receptor beta-selective agonist resmetirom (Madrigal Pharmaceuticals) in patients with NASH and associated cirrhosis in a pivotal phase 3 clinical trial. The primary results of the MAESTRO-NASH (NCT03900429) trial were reported here at the European Association for the Study of the Liver (EASL) Congress 2023. 2023-06-22

Family physicians are the only providers of care for most patients with several chronic diseases, according to new research. 2023-07-03

Diets containing higher amounts of certain food categories appear to be protective against cardiovascular (CV) disease and premature death, suggests a new study with a broad international scope. Most of the protective food categories are in line with standard dietary guidelines for good health, but one that may be heart-protective is not usually included in such recommendations. 2023-07-11

Although multiple international medical societies over recent years have recommended lowering the threshold for bariatric surgery to a body mass index (BMI) of 30-35 (class 1 obesity) in certain patients (see box), very few patients in this weight category have had such surgery, according to a new study. 2023-07-14

Most Americans are unconcerned about skin cancer even if they are at risk, especially Gen Zers, according to a study conducted for the American Academy of Dermatology as part of its #PracticeSafeSun initiative. 2023-07-21